Companies similar to StemCyte India Therapeutics for Relationship Executive in Ahmedabad
![]()
StemCyte India Therapeutics
Relationship Executive Salary
1 - 2 years exp. (3 salaries) | ₹2.8 L/yr - ₹3.2 L/yr |
Company name | Avg Annual Salary | Open Jobs |
---|---|---|
![]() ICICI Prudential Mutual Fund Relationship Executive Salary
0 - 4 years exp. (17 salaries) | ₹2.8 L/yr - ₹4.3 L/yr | |
![]() Axis Bank Relationship Executive Salary
0 - 4 years exp. (15 salaries) | ₹1.5 L/yr - ₹3.3 L/yr | |
Login to view exact salary
| ||
![]() Fedbank Financial Services Relationship Executive Salary
2 - 8 years exp. (9 salaries) | ₹2.2 L/yr - ₹4.4 L/yr | |
![]() Quess Relationship Executive Salary
0 - 3 years exp. (7 salaries) | ₹1.5 L/yr - ₹2.4 L/yr | |
![]() CALIBEHR Relationship Executive Salary
0 - 5 years exp. (7 salaries) | ₹1.6 L/yr - ₹2.7 L/yr | |
Experience wise StemCyte India Therapeutics Relationship Executive salaries in Ahmedabad
Last Updated: 20 Sep 2023
Experience | Avg Annual Salary |
---|---|
1 year (AmbitionBox Estimate) |
₹2.5
L/yr
- ₹3.2
L/yr
|
Login to view exact salary
| |
2 years (AmbitionBox Estimate) |
₹2.5
L/yr
- ₹3.2
L/yr
|
Similar Designation salaries in StemCyte India Therapeutics
Top skills at StemCyte India Therapeutics for Relationship Executive
Salary related reviews for StemCyte India Therapeutics
Discover interview dos and don'ts from real experiences
StemCyte India Therapeutics Relationship Executive Salary FAQs
Experience | Average Salary Range |
---|---|
1 year | ₹2.5 Lakhs to ₹3.2 Lakhs per year |
2 years | ₹2.5 Lakhs to ₹3.2 Lakhs per year |
Tell us how to improve this page.
- Home >
- Salaries >
- StemCyte India Therapeutics Salaries >
- StemCyte India Therapeutics Relationship Executive Salaries >
- StemCyte India Therapeutics Relationship Executive Salaries in Ahmedabad
StemCyte India Therapeutics Relationship Executive salary
in
Ahmedabad
ranges between ₹2.8
Lakhs to ₹3.2
Lakhs with an average annual salary of
₹. Salary estimates are based on
3
StemCyte India Therapeutics latest salaries received from various employees of
StemCyte India Therapeutics.